PT Kalbe Farma Tbk · IDX:KLBF
PT Kalbe Farma Tbk — FY2012 Earnings Presentation
18 slides from PT Kalbe Farma Tbk's earnings presentation, February 2013
Slide 1: Analyst Gathering
Analyst Gathering February 2013 Excellence in Execution
Slide 2: Table of Contents
Table of Contents BUSINESS OVERVIEW 2012 8 OUR STRATEGIES IN 2013 13 Excellence in Execution 2
Slide 3: Business Overview 2012
BUSINESS OVERVIEW 2012 3 Excellence in Execution
Slide 4: Business Overview 2012
BUSINESS OVERVIEW 2012 • Completed new production facility for generic drugs in Cikarang • Construction of oncology plant in Pulogadung Excellence in Execution 4
Slide 5: Business Overview 2012
BUSINESS OVERVIEW 2012 • Launched new innovative products • Acquisition of PT Hale International • Established a joint venture company PT Kalbe Milko Indonesia Excellence in Execution 5
Slide 6: Business Overview 2012
BUSINESS OVERVIEW 2012 • Expansion of distribution and logistics facilities Banjarmasin Jember Surakarta Banda Aceh Denpasar • Multi-channel customer touch points : Kalbe e-store, Kalbe Family Rewards Card, Kalbe Home Delivery, Kalbe Customer Care • Continued to improve retail health service busines
Slide 7: Business Overview 2012
BUSINESS OVERVIEW 2012 • Continued regional expansion Diabetasol and Extra Joss Events in the Philippines Long-lasting kick Excellence in Execution 7
Slide 8: Indicative Results 2012
Indicative Results 2012 Strong Top Line Growth in All Segments Net Sales (in Rp Bn) 24.9% 31 Dec 2011 (Audited) 31 Dec 2012 (Unaudited) 13,630 10,912 33.7% 18.4% 24.5% 16.8% 5,179 3,873 3,288 3,012 2,778 2,420 1,842 2,151 Prescription PharmaceuticalsConsumer Health Nutritionals Distribution & Logist
Slide 9: Indicative Results 2012
Indicative Results 2012 Improved operating expenses efficiency Gross Profit Margin Operating Expenses to Net Sales Ratios 32.8% 31.6% -1.2% - 3.0% 0.8% 0.7% 5.4% 4.9% 50.9% 47.8% Selling & Marketing General & 26.6% 26.0% Administrative Research & Development 31 Dec 2011 31 Dec 2012 31 Dec 2011 31 De
Slide 10: Indicative Results 2012
Indicative Results 2012 Strong Earnings Growth Income Before Tax Net Income (in Rp bn) (in Rp bn) +15.1% +16.8% 2,288 1,732 1,987 1,482 31 Dec 2011 (Audited) 31 Dec 2012 (Unaudited) 31 Dec 2011 (Audited) 31 Dec 2012 (Unaudited) • Income before tax margin declined from • Net income margin declined fr
Slide 11: Our Strategies in 2013
OUR STRATEGIES IN 2013 11 Excellence in Execution
Slide 12: Strategies for 2013
STRATEGIES FOR 2013 1. Improve marketing and sales effectiveness Excellence in Execution
Slide 13: Strategies for 2013
STRATEGIES FOR 2013 1. Improve marketing and sales effectiveness CORPORATE BRANDING 13 Excellence in Execution
Slide 14: Strategies for 2013
STRATEGIES FOR 2013 2. Strengthen business portfolio through innovation and M&A 14 Excellence in Execution
Slide 15: Strategies for 2013
STRATEGIES FOR 2013 3. Go global – deeper ASEAN penetration with more product offering Excellence in Execution 15
Slide 16: Strategies for 2013
STRATEGIES FOR 2013 4. Expand distribution coverage New branches and existing Additional trucks & motorcycles branch capacity expansion New RDC Excellence in Execution 16
Slide 17: Strategies for 2013
STRATEGIES FOR 2013 5. Enhance human capital development Excellence in Execution 17
Slide 18: Outlook 2013
OUTLOOK 2013 Earnings Guidance 2013 1. Year-on-year Sales Growth 15% - 18% 2. Operating Profit Margin 16.0% -17.0% 3. Earnings per Share growth of 15% - 18% 4. Dividend payout ratio minimum 50% • Capex Rp 1 – 1.5 Tn for production capacity and distribution network expansion • Cancellation of Treasur